ABMD (ISIN: US0036541003)
Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients.
MARKET: Nasdaq
www.abiomed.com
Fair value: $ 126
Discount: 11%
Average yearly return: 57%
Yield: N/A
Outperformer
October 27, 2016
Abiomed announces 16Q2 revenue of $103 million, up 35% over prior year GAAP earnings per share $0.20 Sees 2017 revenue $435 million to $445 million The company currently has no debt
Abiomed, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients.
MARKET: Nasdaq
www.abiomed.com
Fair value: $ 126
Discount: 11%
Average yearly return: 57%
Yield: N/A
Outperformer
October 27, 2016
Abiomed announces 16Q2 revenue of $103 million, up 35% over prior year GAAP earnings per share $0.20 Sees 2017 revenue $435 million to $445 million The company currently has no debt
No comments:
Post a Comment